{"id":"NCT02294474","sponsor":"Sanofi","briefTitle":"Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin Glargine","officialTitle":"Six-month, Randomized, Open-label, Parallel-group Comparison of the Insulin Analog SAR342434 to Humalog® in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin Glargine","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-01","primaryCompletion":"2016-02","completion":"2016-02","firstPosted":"2014-11-19","resultsPosted":"2018-01-18","lastUpdate":"2018-01-18"},"enrollment":505,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"SAR342434","otherNames":[]},{"type":"DRUG","name":"Humalog","otherNames":["Insulin Lispro"]},{"type":"DRUG","name":"insulin glargine HOE901","otherNames":["Lantus®"]}],"arms":[{"label":"SAR342434","type":"EXPERIMENTAL"},{"label":"Humalog","type":"ACTIVE_COMPARATOR"}],"summary":"Primary Objective:\n\nTo demonstrate non-inferiority of SAR342434 versus Humalog in glycated hemoglobin A1c (HbA1c) change from baseline to Week 26 in participants with type 2 diabetes mellitus (T2DM) also using insulin glargine.\n\nSecondary Objectives:\n\nTo assess the immunogenicity of SAR342434 and Humalog in terms of positive/negative status and antibody titers at baseline and during the course of the study; To assess the relationship of anti-insulin antibodies with efficacy and safety. To assess the efficacy of SAR342434 and Humalog on: proportion of participants reaching target HbA1c \\<7.0% and \\<=6.5%, fasting plasma glucose (FPG) and self-measured plasma glucose (SMPG) profiles, and insulin dose.\n\nTo assess safety of SAR342434 and Humalog.","primaryOutcome":{"measure":"Change in HbA1c From Baseline to Week 26","timeFrame":"Baseline, Week 26","effectByArm":[{"arm":"SAR342434","deltaMin":-0.92,"sd":0.051},{"arm":"Humalog","deltaMin":-0.85,"sd":0.051}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":13},"locations":{"siteCount":103,"countries":["United States","Argentina","Chile","Colombia","Germany","Hungary","Italy","Romania","Russia","South Korea","Spain","Turkey (Türkiye)"]},"refs":{"pmids":["29232162"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":14,"n":253},"commonTop":[]}}